Company registration number 08010381 (England and Wales)
PREMIER HEALTH PRODUCTS LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2025
PAGES FOR FILING WITH REGISTRAR
PREMIER HEALTH PRODUCTS LTD
COMPANY INFORMATION
Directors
Mr A J Petros
Mr F H Petros
Mr K P Street
Company number
08010381
Registered office
Falkland Close
Charter Avenue Industrial Estate
Coventry
West Midlands
CV4 8AU
Accountants
Burgis & Bullock
23-25 Waterloo Place
Leamington Spa
Warwickshire
CV32 5LA
PREMIER HEALTH PRODUCTS LTD
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 10
PREMIER HEALTH PRODUCTS LTD
BALANCE SHEET
AS AT
31 MAY 2025
31 May 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
4
2,666,804
2,659,638
Current assets
Stocks
715,294
667,235
Debtors
5
377,416
327,260
Cash at bank and in hand
396,045
501,776
1,488,755
1,496,271
Creditors: amounts falling due within one year
6
(1,248,168)
(1,129,465)
Net current assets
240,587
366,806
Total assets less current liabilities
2,907,391
3,026,444
Creditors: amounts falling due after more than one year
7
(1,270,385)
(1,373,028)
Provisions for liabilities
(128,393)
(119,011)
Net assets
1,508,613
1,534,405
Capital and reserves
Called up share capital
8
101
101
Profit and loss reserves
1,508,512
1,534,304
Total equity
1,508,613
1,534,405
PREMIER HEALTH PRODUCTS LTD
BALANCE SHEET (CONTINUED)
AS AT
31 MAY 2025
31 May 2025
- 2 -

For the financial year ended 31 May 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 21 January 2026 and are signed on its behalf by:
Mr A J Petros
Director
Company registration number 08010381 (England and Wales)
PREMIER HEALTH PRODUCTS LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2025
- 3 -
1
Accounting policies
Company information

Premier Health Products Ltd is a private company limited by shares incorporated in England and Wales. The registered office is Falkland Close, Charter Avenue Industrial Estate, Coventry, West Midlands, CV4 8AU.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover represents amounts receivable for vitamin supplements net of VAT and trade discounts.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

1.3
Intangible fixed assets - goodwill

Acquired goodwill is written off in equal annual instalments over its estimated useful economic life of 10 years.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

PREMIER HEALTH PRODUCTS LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2025
1
Accounting policies
(Continued)
- 4 -

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Land and buildings Freehold
- Land is not depreciated, buildings 2% straight line
Plant and machinery
- 15% reducing balance
Fixtures, fittings & equipment
- 15% reducing balance
Computer equipment
- 4 years straight line
Office equipment
- 4 years straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

1.6
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.7
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

PREMIER HEALTH PRODUCTS LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2025
1
Accounting policies
(Continued)
- 5 -
1.8
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.9
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

PREMIER HEALTH PRODUCTS LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2025
1
Accounting policies
(Continued)
- 6 -
1.10
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.11
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.12
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

PREMIER HEALTH PRODUCTS LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2025
1
Accounting policies
(Continued)
- 7 -
1.13
Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the lease s asset are consumed.

1.14
Government grants

Government grants are recognised at the fair value of the asset receive d or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.

Government grants relating to turnover are recognised as income over the periods when the related costs are incurred. Grants relating to an asset are recognised in income systematically over the asset's expected useful life. If part of such a grant is deferred it is recognised as deferred income rather than being deducted from the asset's carrying amount.

1.15
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was 3 0 (2024: 32).

PREMIER HEALTH PRODUCTS LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2025
- 8 -
3
Intangible fixed assets
Goodwill
£
Cost
At 1 June 2024 and 31 May 2025
500,000
Amortisation and impairment
At 1 June 2024 and 31 May 2025
500,000
Carrying amount
At 31 May 2025
-
0
At 31 May 2024
-
0
4
Tangible fixed assets
Land and buildings Freehold
Plant and machinery
Fixtures, fittings & equipment
Computer equipment
Total
£
£
£
£
£
Cost
At 1 June 2024
2,318,850
494,438
444,036
36,341
3,293,665
Additions
-
0
82,345
81,776
7,786
171,907
Disposals
-
0
(10,000)
-
0
-
0
(10,000)
At 31 May 2025
2,318,850
566,783
525,812
44,127
3,455,572
Depreciation and impairment
At 1 June 2024
203,532
185,033
214,998
30,464
634,027
Depreciation charged in the year
37,577
71,140
44,505
3,788
157,010
Eliminated in respect of disposals
-
0
(2,269)
-
0
-
0
(2,269)
At 31 May 2025
241,109
253,904
259,503
34,252
788,768
Carrying amount
At 31 May 2025
2,077,741
312,879
266,309
9,875
2,666,804
At 31 May 2024
2,115,318
309,405
229,038
5,877
2,659,638

PREMIER HEALTH PRODUCTS LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2025
- 9 -
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
275,208
253,054
Other debtors
102,208
74,206
377,416
327,260
6
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans
94,600
77,056
Trade creditors
659,306
592,183
Corporation tax
28,060
39,826
Other taxation and social security
29,157
22,617
Other creditors
437,045
397,783
1,248,168
1,129,465

Included in bank loans is £60,000 relating to a mortgage (2024: £44,496). The mortgage is secured by a debenture comprising of a fixed and floating charge over the company's assets, together with a negative pledge.

7
Creditors: amounts falling due after more than one year
2025
2024
£
£
Bank loans and overdrafts
1,270,385
1,370,969
Other creditors
-
0
2,059
1,270,385
1,373,028

Included in bank loans is £1,033,769 relating to a mortgage (2024: £1,098,856). The mortgage is secured by a debenture comprising of a fixed and floating charge over the company's assets, together with a negative pledge.

PREMIER HEALTH PRODUCTS LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2025
- 10 -
8
Called up share capital
2025
2024
£
£
Ordinary share capital
Issued and fully paid
101 Ordinary Shares of £1 each
101
101
9
Capital commitments

Amounts contracted for but not provided in the financial statements:

2025
2024
£
£
Acquisition of tangible fixed assets
121,271
-
10
Related party transactions

As at 31 May 2025 Premier Health Products Ltd owed £303,669 (2024: £333,010) by way of directors loan accounts. These loans are interest free with no fixed date for repayment.

2025-05-31 2024-06-01 false false false 22 January 2026 CCH Software CCH Accounts Production 2025.200 No description of principal activity Mr S J Petros deceased Mr A J Petros Mr F H Petros Mr K P Street 30 32 08010381 2024-06-01 2025-05-31 08010381 bus:Director2 2024-06-01 2025-05-31 08010381 bus:Director3 2024-06-01 2025-05-31 08010381 bus:Director4 2024-06-01 2025-05-31 08010381 bus:Director1 2024-06-01 2025-05-31 08010381 bus:RegisteredOffice 2024-06-01 2025-05-31 08010381 2025-05-31 08010381 2024-05-31 08010381 core:LandBuildings core:OwnedOrFreeholdAssets 2025-05-31 08010381 core:PlantMachinery 2025-05-31 08010381 core:FurnitureFittings 2025-05-31 08010381 core:ComputerEquipment 2025-05-31 08010381 core:LandBuildings core:OwnedOrFreeholdAssets 2024-05-31 08010381 core:PlantMachinery 2024-05-31 08010381 core:FurnitureFittings 2024-05-31 08010381 core:ComputerEquipment 2024-05-31 08010381 core:CurrentFinancialInstruments core:WithinOneYear 2025-05-31 08010381 core:CurrentFinancialInstruments core:WithinOneYear 2024-05-31 08010381 core:ShareCapital 2025-05-31 08010381 core:ShareCapital 2024-05-31 08010381 core:RetainedEarningsAccumulatedLosses 2025-05-31 08010381 core:RetainedEarningsAccumulatedLosses 2024-05-31 08010381 core:ShareCapitalOrdinaryShareClass1 2025-05-31 08010381 core:ShareCapitalOrdinaryShareClass1 2024-05-31 08010381 core:Goodwill 2024-06-01 2025-05-31 08010381 core:LandBuildings core:OwnedOrFreeholdAssets 2024-06-01 2025-05-31 08010381 core:PlantMachinery 2024-06-01 2025-05-31 08010381 core:FurnitureFittings 2024-06-01 2025-05-31 08010381 core:ComputerEquipment 2024-06-01 2025-05-31 08010381 core:NetGoodwill 2024-05-31 08010381 core:NetGoodwill 2025-05-31 08010381 core:NetGoodwill 2024-05-31 08010381 core:LandBuildings core:OwnedOrFreeholdAssets 2024-05-31 08010381 core:PlantMachinery 2024-05-31 08010381 core:FurnitureFittings 2024-05-31 08010381 core:ComputerEquipment 2024-05-31 08010381 2024-05-31 08010381 core:CurrentFinancialInstruments 2025-05-31 08010381 core:CurrentFinancialInstruments 2024-05-31 08010381 core:WithinOneYear 2025-05-31 08010381 core:WithinOneYear 2024-05-31 08010381 core:Non-currentFinancialInstruments 2025-05-31 08010381 core:Non-currentFinancialInstruments 2024-05-31 08010381 bus:PrivateLimitedCompanyLtd 2024-06-01 2025-05-31 08010381 bus:SmallCompaniesRegimeForAccounts 2024-06-01 2025-05-31 08010381 bus:FRS102 2024-06-01 2025-05-31 08010381 bus:AuditExemptWithAccountantsReport 2024-06-01 2025-05-31 08010381 bus:FullAccounts 2024-06-01 2025-05-31 08010381 2023-06-01 2024-05-31 xbrli:pure xbrli:shares iso4217:GBP